Skip to content

Effect of Curcumin in Treatment of Pediatric Intractable Epilepsy

The Effect of Curcumin on Reducing the Number of Seizures and Inflammatory Cytokines in Patients with Intractable Pediatric Epilepsy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130811014330N7
Enrollment
22
Registered
2019-12-26
Start date
2015-07-23
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric intractable epilepsy. Epilepsy, unspecified, intractable, without status epilepticus

Interventions

Intervention 1: Intervention group 1: Patients were given 4 mg/kg curcumin solution daily for four weeks (Sinacurcumin®, each drop of solution contains 4 mg nanocurcumin). After a two-week washout per

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Months to 16 Years

Inclusion criteria

Inclusion criteria: Have at least 4 epileptic seizures in the last 4 weeks. Has been using anticonvulsant drugs for at least the last 1 month. The child's parents have informed consent. Not having a history of exacerbating seizures. Not having a cardiovascular, liver, or kidney disorder.

Exclusion criteria

Exclusion criteria: Diagnosing a curable cause for the epilepsy. Epilepsy is secondary to a progressive or neurodegenerative brain disorder. Having a history of status epilepsy within the past 3 months. Having multiple and uncountable seizures. Lack of cooperation in taking the medicines properly.

Design outcomes

Primary

MeasureTime frame
Number of seizure attacks. Timepoint: baseline (before starting intervention), 4, 6,10 weeks after intervention. Method of measurement: based on clinical report of attacks.

Secondary

MeasureTime frame
. Timepoint: . Method of measurement: .

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Reza Rahimi

Mashhad University of Medical Sciences

rahimihr891@mums.ac.ir+98 51 1800 2288

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026